Meeting NewsVideo
April 20, 2019
VIENNA — In this exclusive video from the 2019 International Liver Congress, Akin Akinc, PhD, of Alnylam Pharmaceuticals, discusses results of…
Meeting NewsVideo
April 18, 2019
CHICAGO — In this exclusive video from the International Liver Congress 2019, Marc Bulterys, MD, PhD, team leader of the Global Hepatitis…
Meeting News
April 18, 2019
VIENNA — In the face of the remaining gaps in the hepatitis C care cascade, timely screening, monitoring and linkage to care by general…
Meeting News
April 17, 2019
VIENNA — Researchers reported an increasing prevalence of alcoholic cirrhosis in a large representative Canadian population, especially among…
Meeting NewsVideo
April 17, 2019
VIENNA — In this exclusive video from the International Liver Congress 2019, Marlyn J. Mayo, MD, from The University of Texas, presents…
Meeting News
April 16, 2019
VIENNA — Patients with hepatitis C genotype 3 and compensated cirrhosis had higher rates of sustained virologic response after treatment with…
Meeting NewsVideo
April 16, 2019
VIENNA — In this exclusive video from the International Liver Congress 2019, Bajaj S. Jasmohan, MD, from the Virginia Commonwealth University…
Meeting News
April 13, 2019
VIENNA — A combination of a core protein inhibitor and nucleos(t)ide analogue therapy brought hepatitis B virus RNA and DNA below levels of…
Meeting News
April 13, 2019
VIENNA — When patients do not fully respond to ursodeoxycholic acid, a new peroxisome proliferator-activated receptor alpha and delta agonist…
Meeting News
April 13, 2019
VIENNA — Emricasan missed its primary endpoint of hepatic venous pressure gradient reduction in all patients with nonalcoholic…